United Kingdom · Question · Written question
UIN 5397
Blood Cancer: Medical Treatments
Original
Introduced
20 January 2020
Last action
29 January 2020 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
29 January 2020
Summary
To ask the Secretary of State for Health and Social Care, how many people with (a) relapsed diffuse large B-cell lymphoma and (b) children with relapsed acute lymphoblastic leukaemia have received CAR-T therapies in each of the last five years.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
20 January 2020
Written question
To ask the Secretary of State for Health and Social Care, how many people with (a) relapsed diffuse large B-cell lymphoma and (b) children with relapsed acute lymphoblastic leukaemia have received CAR-T therapies in each of the last five years.
Source: Commons
29 January 2020
Answer
Chimeric Antigen Receptor T-cell (CAR-T) therapies have been available since November 2018 (acute lymphoblastic leukaemia) and December 2018 (relapsed DLBCL). The first patients were reinfused in January 2019. Therefore, the only data we have for the last...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2020-01-20/5397
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1171877
- uk · wq-1171877 · source updated 29 January 2020